文献
J-GLOBAL ID:201802282259545011
整理番号:18A0017808
Salmonella Typhiの制御されたヒト感染モデルを用いた腸チフスの予防におけるVi破傷風トキソイド結合ワクチンの有効性と免疫原性:無作為化対照,2b相試験【Powered by NICT】
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
著者 (16件):
Jin Celina
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Gibani Malick M
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Moore Maria
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Juel Helene B
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Jones Elizabeth
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Meiring James
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Harris Victoria
(Nuffield Department of Primary Care Health Sciences, University of Oxford, UK)
,
Gardner Jonathan
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Nebykova Anna
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Kerridge Simon A
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Hill Jennifer
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Thomaides-Brears Helena
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Blohmke Christoph J
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
,
Yu Ly-Mee
(Nuffield Department of Primary Care Health Sciences, University of Oxford, UK)
,
Angus Brian
(Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK)
,
Pollard Andrew J
(Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK)
資料名:
Lancet
(Lancet)
巻:
390
号:
10111
ページ:
2472-2480
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)